You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKesson
McKinsey
Baxter
Merck

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

CHLORHEXIDINE GLUCONATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Chlorhexidine Gluconate patents expire, and when can generic versions of Chlorhexidine Gluconate launch?

Chlorhexidine Gluconate is a drug marketed by Sage Prods, Bajaj, Hi Tech Pharma, Lyne, Pharm Assoc, Wockhardt Bio Ag, Xttrium, Becton Dickinson, and Kendall Il. and is included in ten NDAs. There are five patents protecting this drug.

This drug has three patent family members in one country.

The generic ingredient in CHLORHEXIDINE GLUCONATE is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.

US ANDA Litigation and Generic Entry Outlook for Chlorhexidine Gluconate

A generic version of CHLORHEXIDINE GLUCONATE was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.

  Start Trial

Drug patent expirations by year for CHLORHEXIDINE GLUCONATE
Drug Prices for CHLORHEXIDINE GLUCONATE

See drug prices for CHLORHEXIDINE GLUCONATE

Drug Sales Revenue Trends for CHLORHEXIDINE GLUCONATE

See drug sales revenues for CHLORHEXIDINE GLUCONATE

Recent Clinical Trials for CHLORHEXIDINE GLUCONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San FranciscoPhase 2
University of Wisconsin, MadisonPhase 4
Zagazig UniversityPhase 1/Phase 2

See all CHLORHEXIDINE GLUCONATE clinical trials

Pharmacology for CHLORHEXIDINE GLUCONATE
Physiological EffectDecreased Cell Wall Integrity
Medical Subject Heading (MeSH) Categories for CHLORHEXIDINE GLUCONATE
Paragraph IV (Patent) Challenges for CHLORHEXIDINE GLUCONATE
Tradename Dosage Ingredient NDA Submissiondate
HIBICLENS SPONGE;TOPICAL chlorhexidine gluconate 018423

US Patents and Regulatory Information for CHLORHEXIDINE GLUCONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sage Prods CHLORHEXIDINE GLUCONATE chlorhexidine gluconate CLOTH;TOPICAL 021669-001 Apr 25, 2005 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
Hi Tech Pharma CHLORHEXIDINE GLUCONATE chlorhexidine gluconate SOLUTION;DENTAL 074356-001 May 7, 1996 AT RX No No   Start Trial   Start Trial   Start Trial
Sage Prods CHLORHEXIDINE GLUCONATE chlorhexidine gluconate CLOTH;TOPICAL 021669-001 Apr 25, 2005 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
Bajaj CHLORHEXIDINE GLUCONATE chlorhexidine gluconate SOLUTION;TOPICAL 020111-001 Sep 11, 1997 OTC No No   Start Trial   Start Trial   Start Trial
Lyne CHLORHEXIDINE GLUCONATE chlorhexidine gluconate SOLUTION;DENTAL 074291-001 Dec 28, 1995 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Colorcon
Harvard Business School
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.